Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of metabolic disease. As a part of a well-established larger network of researchers in metabolism and cardiovascular disease we focus on identifying early disease mechanisms and novel therapeutic targets, taking
-
both biochemical and cellular assays. To support clinical findings and development we need to further investigate biomarkers, combination treatments, and potential resistance mechanisms to obtain a
-
responses to acute infections and cancer. Using a combination of several state-of-the-art single-cell technologies we strive to understand mechanisms underlying the generation, maintenance and consequences
-
the knowledge of diseases and their mechanisms, many promising therapeutic approaches are still clinically unavailable. There is no effective way to deliver these therapies to the right organ at the right dose
-
collaborative atmosphere within the group. Required qualifications: Doctoral degree in Immunology or a related field a solid theoretical and experiemental background in cellular immunology excellent skills in
-
the Karolinska University Hospital? Are you interested in preclinical, translational and clinical research about solid tumors in adults? Are you interested in oncological treatment and would like to lead the
-
. Application for medical applications, medical imaging, or fluid mechanics are desired but nor required. Specific areas of relevance include, but are not limited to generative networks, super-resolution imaging
-
Do you want to contribute to improving human health? Division The research in Galina Selivanova’s lab is focused on the identification and studies of the mechanisms and the impact on the tumor
-
. The department has 12 research groups, about 110 PhD students and about 140 employees. The position is placed in the PRIME health research group (Prevention, Intervention and Mechanisms in Public Health
-
We are looking for an ambitious postdoc with solid single-cell immunology skills to join our highly accomplished team of immunologists in a project funded by the Swedish Cancer Society. We offer a